Serturner Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 02-07-2024
- Paid Up Capital ₹ 8.42 M
as on 02-07-2024
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.20 M
as on 02-07-2024
- Revenue -35.54%
(FY 2023)
- Profit -61.82%
(FY 2023)
- Ebitda -169.72%
(FY 2023)
- Net Worth 213.42%
(FY 2023)
- Total Assets 41.30%
(FY 2023)
About Serturner Labs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.42 M.
The company currently has active open charges totaling ₹1.20 M.
Gururaja Sandur, Rohan Shetty, and Vidya Shetty serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC313503
- Company No.
313503
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Serturner Labs Private Limited offer?
Serturner Labs Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Oxygen Concentrator, Nebulizer Machine & Parts, Patient Monitoring System, Medical Laboratory Instruments, IVDs & Analyzers, Autoclaves, Sterilizers & Incubators, Cold Chain Equipment, Vaccine Carriers, Philips Oxygen Concentrator.
Who are the key members and board of directors at Serturner Labs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gururaja Sandur  | Director | 20-Oct-2018 | Current |
| Rohan Shetty | Director | 05-Sep-2018 | Current |
| Vidya Shetty | Director | 05-Sep-2018 | Current |
Financial Performance of Serturner Labs.
Serturner Labs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 35.54% decrease. The company also saw a substantial fall in profitability, with a 61.82% decrease in profit. The company's net worth Soared by an impressive increase of 213.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Serturner Labs?
In 2022, Serturner Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.12 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 May 2023 | Others | ₹1.20 M | Open |
How Many Employees Work at Serturner Labs?
Unlock and access historical data on people associated with Serturner Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Serturner Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serturner Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.